Honecker F - Search Results

1

Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancer.

Dyshlovoy SA, Otte K, Alsdorf WH, Hauschild J, Lange T, Venz S, Bauer CK, Bähring R, Amann K, Mandanchi R, Schumacher U, Schröder-Schwarz J, Makarieva TN, Guzii AG, Tabakmakher KM, Fedorov SN, Shubina LK, Kasheverov IE, Ehmke H, Steuber T, Stonik VA, Bokemeyer C, Honecker F, von Amsberg G. Dyshlovoy SA, et al. Among authors: honecker f. Oncotarget. 2016 Oct 25;7(43):69703-69717. doi: 10.18632/oncotarget.11941. Oncotarget. 2016. PMID: 27626485 Free PMC article.

2

Colorectal cancer in the elderly: is palliative chemotherapy of value?

Honecker F, Köhne CH, Bokemeyer C. Honecker F, et al. Drugs Aging. 2003;20(1):1-11. doi: 10.2165/00002512-200320010-00001. Drugs Aging. 2003. PMID: 12513112 Review.

3

Xeroderma pigmentosum group a protein and chemotherapy resistance in human germ cell tumors.

Honecker F, Mayer F, Stoop H, Oosterhuis JW, Koch S, Bokemeyer C, Looijenga LH. Honecker F, et al. Lab Invest. 2003 Oct;83(10):1489-95. doi: 10.1097/01.lab.0000090221.95883.41. Lab Invest. 2003. PMID: 14563950 Free article.

4

Safe use of oxaliplatin in a patient with metastatic breast cancer and combined renal and hepatic failure.

Honecker FU, Brümmendorf TH, Klein O, Bokemeyer C. Honecker FU, et al. Onkologie. 2006 Jun;29(6):273-5. doi: 10.1159/000093032. Onkologie. 2006. PMID: 16783902

5

Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.

Mueller S, Schittenhelm M, Honecker F, Malenke E, Lauber K, Wesselborg S, Hartmann JT, Bokemeyer C, Mayer F. Mueller S, et al. Among authors: honecker f. Int J Oncol. 2006 Aug;29(2):471-9. Int J Oncol. 2006. PMID: 16820891

6

Tolerance to chemotherapy in elderly patients with cancer.

Wedding U, Honecker F, Bokemeyer C, Pientka L, Höffken K. Wedding U, et al. Among authors: honecker f. Cancer Control. 2007 Jan;14(1):44-56. doi: 10.1177/107327480701400106. Cancer Control. 2007. PMID: 17242670 Free article. Review.

7

An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors.

Oechsle K, Honecker F, Kollmannsberger C, Rick O, Grünwald V, Mayer F, Hartmann JT, Bokemeyer C. Oechsle K, et al. Among authors: honecker f. Anticancer Drugs. 2007 Mar;18(3):273-6. doi: 10.1097/CAD.0b013e328011fd99. Anticancer Drugs. 2007. PMID: 17264758 Clinical Trial.

8

Comparative proteome, transcriptome, and genome analysis of a gonadal and an extragonadal germ cell tumor cell line.

Glaesener S, Honecker F, Veltman IM, Gillis AJ, Rohlfing T, Streichert T, Otto B, Brummendorf TH, Looijenga LH, Bokemeyer C, Balabanov S. Glaesener S, et al. Among authors: honecker f. J Proteome Res. 2008 Sep;7(9):3890-9. doi: 10.1021/pr800173g. Epub 2008 Jul 22. J Proteome Res. 2008. PMID: 18642941

9

Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.

Honecker F, Wermann H, Mayer F, Gillis AJ, Stoop H, van Gurp RJ, Oechsle K, Steyerberg E, Hartmann JT, Dinjens WN, Oosterhuis JW, Bokemeyer C, Looijenga LH. Honecker F, et al. J Clin Oncol. 2009 May 1;27(13):2129-36. doi: 10.1200/JCO.2008.18.8623. Epub 2009 Mar 16. J Clin Oncol. 2009. PMID: 19289622

10

Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors.

Oechsle K, Bokemeyer C, Honecker F. Oechsle K, et al. Among authors: honecker f. J Cancer Res Clin Oncol. 2010 Jan;136(1):165-7. doi: 10.1007/s00432-009-0677-2. Epub 2009 Sep 16. J Cancer Res Clin Oncol. 2010. PMID: 19760194 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page